Your Recovery
Starts Here.

Is Medication-Assisted Treatment Right for You in Riverside?

medication assisted treatment riverside

Addiction recovery in California has changed significantly with the widespread adoption of evidence-based medical treatment. Medication Assisted Treatment Riverside programs now give people with opioid and alcohol use disorders a clinically validated path that combines FDA-approved medications with behavioral therapy, reducing cravings, easing withdrawal, and dramatically lowering the risk of relapse.

Research from the Substance Abuse and Mental Health Services Administration (SAMHSA) confirms that MAT is one of the most effective tools available for treating substance use disorders, outperforming abstinence-only approaches in both treatment retention and long-term stability.

Understanding how these programs work, which medications are used, and who is most likely to benefit helps you make informed decisions for yourself or someone you care about. Studies show that MAT reduces opioid-related mortality by as much as 50 percent when paired with counseling and structured support.

Accessing that care locally means fewer barriers between the moment you decide to seek help and the moment treatment begins.


Addiction Treatment that
Just Works

Individualized treatment programs delivered in a comfortable, relaxed setting promote healing in your recovery journey.

Table of Contents

 

What Is Medication-Assisted Treatment?

Medication-assisted treatment, commonly called MAT, is a whole-patient clinical approach that pairs FDA-approved medications with counseling and behavioral therapy to treat opioid and alcohol use disorders. Rather than relying on willpower alone, MAT addresses the neurological dimension of addiction by normalizing brain chemistry, reducing physiological cravings, and blocking the rewarding effects of substances.

This science-backed combination gives people a more stable foundation from which to engage in the deeper psychological work of recovery. You can review MAT benefits in recovery for a fuller picture of what the research shows.

Addiction is a chronic brain disorder, not a moral failure, and the medications used in Medication Assisted Treatment Riverside reflect that clinical reality. They work by attaching to the same brain receptors that opioids and alcohol activate, either quieting withdrawal symptoms or preventing substances from producing a high if a relapse occurs.

Recent research consistently shows that people who receive MAT are significantly more likely to remain in treatment and rebuild stable, productive lives compared to those who receive no pharmacological support. The behavioral therapy component addresses patterns of thought and behavior that fuel substance use, making the two-pronged approach far more effective than either medication or therapy alone.

MAT is not a shortcut or a replacement for one substance with another, despite a common misconception. The medications are carefully dosed, closely monitored, and prescribed as part of a structured clinical plan.

For people dealing with opioid use disorder or alcohol dependence, starting MAT early in treatment reduces the physical discomfort of withdrawal, which is one of the most common reasons people leave treatment before completing it. Staying in treatment longer consistently produces better long-term outcomes across virtually every measure of recovery success.

What Medications Are Used in MAT Programs in Riverside?

Three FDA-approved medications form the foundation of most MAT programs for opioid use disorder: methadone, buprenorphine, and naltrexone. Each works differently, and the right choice depends on your medical history, substance use pattern, and personal recovery goals.

Methadone is a long-acting opioid agonist, meaning it activates opioid receptors at a controlled level to prevent withdrawal and suppress cravings without producing intoxication. Buprenorphine, often prescribed as Suboxone (which combines buprenorphine with naloxone to prevent misuse), is a partial agonist that reduces cravings with a lower risk of dependence than full agonists.

Naltrexone works differently from both. It is an opioid antagonist, meaning it blocks opioid receptors entirely, so if you use opioids while on naltrexone, no euphoric effect occurs. It is available as a daily pill or a monthly extended-release injection called Vivitrol, which some people prefer for its convenience and built-in accountability.

For alcohol use disorder, the primary MAT medications include naltrexone, acamprosate (which helps the brain restore chemical balance after prolonged alcohol use), and disulfiram (which causes unpleasant physical reactions if alcohol is consumed). MAT for alcohol dependence explains how these options compare and when each is most appropriate.

Selecting the right medication requires a thorough clinical assessment conducted by a licensed prescriber. The following factors are commonly evaluated before a medication plan is established:

  • Severity and duration of the substance use disorder
  • History of prior treatment attempts and outcomes
  • Co-occurring mental health conditions
  • Current medical health and any contraindicated conditions
  • Patient preference and lifestyle considerations

Medication selection is not one-size-fits-all, and adjustments are made throughout treatment as your clinical picture evolves. A skilled treatment team monitors your progress closely and adapts the plan accordingly.

Medication Assisted Treatment In Riverside

Who Is a Good Candidate for Medication-Assisted Treatment in Riverside?

Adults diagnosed with moderate to severe opioid use disorder or alcohol use disorder are the primary candidates for MAT. Clinical guidelines developed by SAMHSA and the American Society of Addiction Medicine identify people who have experienced repeated relapse, failed abstinence-based treatment, or face a high overdose risk as especially strong candidates.

Individuals who are currently sober but who have a recently reduced tolerance, such as those who completed detox or left a period of incarceration, are at heightened overdose risk and may benefit significantly from starting MAT promptly.

Co-occurring mental health conditions, such as depression, anxiety, PTSD, or bipolar disorder, do not disqualify someone from MAT. In fact, addressing substance use and mental health simultaneously through dual diagnosis treatment often produces better outcomes for both conditions.

MAT can reduce the anxiety and depression symptoms that frequently accompany early recovery, helping people engage more fully in therapy. If you have questions about eligibility or want to explore what a local MAT program personalized clinical plan looks like.

Pregnancy is another situation where MAT is strongly recommended rather than optional. Methadone and buprenorphine are both considered safe during pregnancy and significantly reduce the risks of preterm birth, low birth weight, and fetal withdrawal compared to untreated opioid dependence.

Adolescents with substance use disorders may also be considered for MAT on a case-by-case basis, with parental involvement and careful clinical oversight. The key principle across all of these groups is that MAT is a medically appropriate, evidence-based intervention, not a last resort.

Addiction Treatment that
Just Works

Individualized treatment programs delivered in a comfortable, relaxed setting promote healing in your recovery journey.

What Our Customers Are Saying

How Does MAT Fit Into a Full Addiction Treatment Program in Riverside?

MAT is most effective when it functions as one component of a comprehensive treatment plan rather than a standalone intervention. At a clinically structured level, that plan typically begins with medical detox, the supervised process of clearing substances from the body while managing withdrawal safely.

MAT medications are often introduced during or immediately after detox to stabilize the patient before the next phase of care begins. Inpatient treatment, which provides round-the-clock clinical support in a residential setting, gives people the space and structure needed to address the psychological roots of addiction while medications manage the physical side.

Outpatient programs allow people to continue MAT while living at home or in a sober living environment, attending therapy sessions and medical appointments on a scheduled basis. Intensive outpatient programs (IOPs) offer a structured middle ground, providing multiple hours of therapy per week without requiring a residential stay.

Aftercare, which includes ongoing counseling, peer support groups such as AA or NA, and continued medication management, is where long-term recovery is built and maintained. Treatment-focused MAT walks through how each level of care connects to support lasting sobriety.

Behavioral therapy is the partner that makes MAT’s medical benefits sustainable. Cognitive behavioral therapy (CBT) helps identify the thought patterns that trigger substance use. Motivational interviewing builds internal motivation and resolves ambivalence about recovery.

Group therapy creates accountability, shared understanding, and a sense of belonging that sustains recovery long after treatment ends. Research consistently shows that people who combine MAT with robust behavioral health support have significantly lower relapse rates than those who use medication alone.

Frequently Asked Questions About MAT for Addiction Recovery

These are some of the most common questions people ask when exploring medication-assisted treatment options for opioid and alcohol use disorders:

  1. What is medication-assisted treatment and how does it work?

    MAT combines FDA-approved medications with counseling and behavioral therapy to treat substance use disorders by normalizing brain chemistry and reducing cravings. The medications used in MAT work by targeting the same receptors that opioids or alcohol affect, either suppressing withdrawal symptoms or blocking the euphoric effect of substances entirely.

  2. Which medications are used in MAT programs?

    For opioid use disorder, the primary medications are methadone, buprenorphine (often as Suboxone), and naltrexone, each working through a different mechanism to reduce cravings and prevent relapse. For alcohol use disorder, naltrexone, acamprosate, and disulfiram are the most commonly prescribed options, selected based on individual medical and clinical factors.

  3. Who is a good candidate for MAT?

    Adults with moderate to severe opioid or alcohol use disorder, particularly those who have experienced relapse or struggled with abstinence-only approaches, are typically strong candidates for MAT. People with reduced opioid tolerance following detox, incarceration, or a period of sobriety are at especially high overdose risk and may benefit most from starting MAT promptly.

  4. What is the success rate of medication-assisted treatment?

    Research shows that MAT produces success rates typically ranging from 40 to 60 percent, significantly improving outcomes compared to treatment without pharmacological support. It also reduces opioid overdose mortality by as much as 50 percent and increases overall treatment retention, which is one of the strongest predictors of long-term recovery.

  5. Does insurance cover MAT programs?

    Most health insurance plans, including Medicaid, Medicare, and private insurance, cover MAT because substance use treatment is classified as an essential health benefit under the Affordable Care Act. Out-of-pocket costs vary by plan, and prior authorization may be required, so contacting your insurer or the treatment facility directly is the fastest way to confirm your specific benefits.

  6. Can you stop MAT abruptly once you start?

    Stopping MAT suddenly is not recommended, as it can trigger uncomfortable withdrawal symptoms and significantly increase the risk of relapse. A structured tapering plan developed with your clinical team allows for a safe, gradual transition off medication when the time is clinically appropriate.

Key Takeaways on Medication Assisted Treatment Riverside

  • Medication Assisted Treatment Riverside pairs FDA-approved medications with behavioral therapy to treat opioid and alcohol use disorders
  • The three core medications for opioid use disorder are methadone, buprenorphine, and naltrexone
  • Strong candidates include anyone with moderate to severe substance use disorder, a history of relapse, or recently reduced opioid tolerance
  • MAT works best as part of a full continuum of care that includes detox, inpatient or outpatient treatment, and aftercare
  • Most insurance plans, including Medicare and Medicaid, cover MAT as an essential health benefit

Substance use disorders respond to treatment, and medication-assisted therapy is among the most clinically supported options available today. The combination of medical stabilization and behavioral support creates lasting change at both the neurological and behavioral levels.

If you or someone you love is ready to take the first step, Resurgence Behavioral Health offers comprehensive MAT and addiction treatment programs in Jurupa Valley, California, with a full continuum of care tailored to your individual needs.

Call our team directly at 855-458-0050 to speak with a clinical specialist, verify your insurance, and begin building your personalized treatment plan today. Getting the right support early makes a measurable difference in long-term outcomes.

Resources

David Rofofsky
David Rofofsky
After growing up in New York, David chose to get help with substance abuse in California because of the state's reputation for top-tier treatment. There, he found the treatment he needed to achieve more than nine years of recovery. He's been in the drug and alcohol addiction rehab industry for eight years and now serves as the Director of Admissions for Resurgence Behavioral Health. David remains passionate about the field because he understands how hard it is to pick up the phone and ask for help. However, once the call is made, someone's life can be saved.


Research | Editorial

Does your Insurance Cover Rehab?

At Resurgence, we accept most PPO insurance. Verify your insurance now.